Microglia brain immune cells are vital in conjunction with the APOE4 gene during the development of Alzheimer’s in mouse models, researchers have found.
List view / Grid view
Filter the results
A new study has shown the possibility of using RNA splicing as a potential molecular target for Alzheimer's disease.
The memory of mice with Alzheimer's greatly improved after they were injected with two newly discovered short peptides.
A study has found a protein which, when depleted, resulted in Alzheimer’s disease symptoms appearing in mouse and brain tissue models.
Researchers have developed a new treatment method which turned glial cells into functioning neurons in mice after stroke.
A compound that promotes the rebuilding of the protective sheath around nerve cells damaged in multiple sclerosis has been developed.
New research is the first to link maladaptive changes in calcium transport by mitochondria to the progression of Alzheimer's disease.
A gene associated with a rare balance disorder also regulates the behaviour of an enzyme that increases the risk for Alzheimer's disease.
Researchers have found that the presence of microglia brain cells allowed plaques to form in the brains of rodents, leading to Alzheimer’s disease.
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
New study finds a promising antagonist that blocks specific interaction between the protein apoE and amyloid precursor protein.
Researchers have found a new drug target for Alzheimer’s disease after identifying a facilitating protein.